Azaspiracid

Azaspiracid is a group of polyether marine toxins originally discovered in mussels from Ireland in 1995. The toxins are produced by small marine dinoflagellates such as Azadinium spinosum and Amphidoma languida. Azaspiracids are responsible for azaspiracid poisoning (AZP), a type of shellfish poisoning.

History[edit | edit source]

Azaspiracid was first identified in 1995 following a human illness outbreak in the Netherlands linked to consumption of mussels from Killary Harbour, Ireland. The toxin was named after the genus Azadinium, which was initially thought to be the source of the toxin. However, subsequent research identified Amphidoma languida as another source.

Structure and properties[edit | edit source]

Azaspiracids are a group of more than 30 related compounds, all of which share a common polycyclic structure composed of a spirocyclic ring system and a carboxylic acid group. The toxins are heat-stable and acid-stable, meaning they are not destroyed by cooking or stomach acid.

Toxicity[edit | edit source]

Azaspiracids are potent toxins that can cause severe illness in humans if ingested. Symptoms of azaspiracid poisoning (AZP) include nausea, vomiting, diarrhea, and stomach cramps. In severe cases, neurological symptoms such as memory loss and confusion may also occur. The toxins are believed to act by disrupting cellular ion channels, leading to a disruption of normal cell function.

Detection and regulation[edit | edit source]

Several methods are available for the detection of azaspiracids in shellfish, including liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assay (ELISA). Regulatory limits for azaspiracids in shellfish have been established by the European Union and other regulatory bodies.

See also[edit | edit source]

Azaspiracid Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.